Navigation Links
Prognostic model developed for MDS related to prior cancer therapy
Date:12/13/2011

SAN DIEGO - A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis, researchers from The University of Texas MD Anderson Cancer Center report at the 53rd Annual Meeting of the American Society of Hematology.

"MDS patients whose disease springs from earlier radiation, chemotherapy or both treatments are usually told that they have a poor prognosis. But by analyzing survival risk factors in a large patient population, we've found these patients fall into good, intermediate and poor prognostic groups," said study leader Guillermo Garcia-Manero, M.D., Ph.D., professor in MD Anderson's Department of Leukemia.

Understanding their differing characteristics will better inform treatment decisions for these patients, Garcia-Manero said.

Myelodysplastic syndrome consists of a group of diseases in which the bone marrow progenitor cells that normally morph into red and white blood cells and platelets fail to respond to normal growth controls. That results in too many progenitor cells (also known as blasts) and too few mature blood cells, and in about 30 percent of patients, the disease progresses to acute myeloid leukemia (AML).

Treatment-related MDS is often more resistant to therapy

Therapy-related MDS generally differs from other MDS cases by having more chromosomal abnormalities, a higher rate of conversions to acute myeloid leukemia and high resistance to standard MDS therapy. Even so, Garcia-Manero notes, a one-size-fits-all poor prognosis is not accurate.

The research team analyzed 1,950 MD Anderson patients treated between 1998 and 2007. It found 438 had a history of one or more previous cancers that were treated before their MDS diagnosis. Of these, 279 cases who had received chemotherapy, radiotherapy or both were analyzed.

A first round of analysis identified at least 15 factors a
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Strong evidence supports prognostic value of circulating tumor cells in breast cancer
2. A novel prognostic marker for biliary atresia
3. Prognostic markers for prostate cancer patients who receive radiation after surgery
4. A prognostic and predictive biomarker for nonsmall cell lung cancer
5. "IPGDx, LLC Announces The Continued Validation Of Its Patented Technology For The Assessment Of Prognosis; PrognostiCheck" Getting the New Information to Patients and Do
6. Model shows how façade pollutants make it into the environment
7. Supercomputer reveals new details behind drug-processing protein model
8. Funding models not associated with better preventive care delivery
9. When errors improve performance: Model describes how experiences influence our perception
10. New Stanford model establishes guidelines for earlier cancer detection
11. UGA researchers develop first mouse model to study important aspect of Alzheimer’s
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prognostic model developed for MDS related to prior cancer therapy
(Date:6/19/2013)... Raton, FL (PRWEB) June 19, 2013 At ... about the positive changes and growth that has occurred over ... nationwide travel club. , Shuman said, "Travel Services has added ... to heights beyond belief. Membership is up, even in ... to meet the demands of members." , Having been in ...
(Date:6/19/2013)... neuron disease Amyotrophic lateral sclerosis (ALS), also known as ... which can be classified into four distinct stages, report ... University of Pennsylvania in the Annals of Neurology ... cord tissues shows, for the first time, how the ... in the central nervous system to other regions of ...
(Date:6/19/2013)... molecule derived from a naturally occurring compound (apocynin), ... mice with Parkinson,s Disease symptoms by preventing deficits ... in the May 28, 2013 edition of ... Ph.D., postdoctoral fellow at the Medical College of ... paper. Balaraman Kalyanaraman, Ph.D., Harry R. & ...
(Date:6/19/2013)... Imprivata ®, a leading global provider of ... OneSign ® leads the single sign-on (SSO) category in ... Services report . CIOs and other healthcare executives iwere ... of its products and the quality of its customer ... integral to their long-term healthcare IT strategy. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The US Food ... a third ultra cohesive gel breast implant, Mentor Worldwide’s MemoryShape™. ... 410 in February 2013. The FDA announced the approval of ... approved for primary augmentations in women 22 years ... any age. , The FDA’s approval comes after six ...
Breaking Medicine News(10 mins):Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery 2
... to the food chain via the Bernard Matthews plant, which ... in early February this year. , ,The Public ... turkey had to pass through the plant situated in Holton ... outbreak of the avian influenza and resumption of production services ...
... believe they may be on the right track ... key they say is stimulation of the occipital nerve. ... head and neck of the sufferers and giving them remotes ... reached separate research groups That included neurologists from the ...
... 8. According to statistics over one lac people Indians are ... cent die as they do not get timely treatment. ... Health Check-up package in connection with World Kidney Day-2007. The ... consultation and urine analysis for random glucose and creatinine. ...
... Want to de-stress, tone up your body or build your confidence? How ... and step on the dance floor// . ,'I tried going ... Then I started going for walks but I got bored of that ... stopped since,' said Suman Vohra, a doctor at the Apollo Hospital here. ...
... Implantable materials that grab stem cells and spur their ... and her colleagues// at MIT have created a new ... transplant environment--a key step in cell-transplant therapies. Scientists are ... well it can help heal fractures. ,"Creating ...
... schools and homes were housed under asbestos roofs. The children ... the repercussion of living their childhood days under asbestos roofs, ... cancer- Mesothelioma. Almost 5% of all lung cancers in the ... ,Mesothelioma is a medical term used to describe a cancer ...
Cached Medicine News:Health News:Doctors Put on Their Dancing Shoes to De-stress 2Health News:Healing Bone With Stem Cells 2
(Date:6/19/2013)... June 19, 2013 Today MedeAnalytics, a ... the next-generation of its Employer Group and ... plans to provide their employer groups an intuitive ... medical and prescription drug claims, network utilization, and ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group and ...
(Date:6/18/2013)... -- , Safinamide significantly improves responder ... add-on to levodopa Safinamide is associated ... fluctuating PD patients as add-on to levodopa ... a research and development company focused on novel ... S.p.A., a pharmaceutical company strongly committed to the ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Three-in-One X3130 Appliance Inlet Module 2
... 2011 First Advantage , a ... solutions, today announced that it has made a significant ... The investment in Workstream was announced by Todd Mavis, ... is a supplier of talent acquisition and talent ...
... 20, 2011 Cardinal Health today announced that this ... show for independent pharmacies, is the largest in the ... This year,s event, taking place July 20-23 ... hotel, features a 100,000-square-foot trade show floor, highlighting buying ...
Cached Medicine Technology:First Advantage Invests in Workstream Inc. 2First Advantage Invests in Workstream Inc. 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 2Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 4
Remote Blower Without Bag-In/Bag-Out Option...
... Ideal for biocompatibility testing at various ... of air through a clean heating ... temperature up to 140F. Transparent panels ... shields allow easy access to the ...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... This fume hood is the ... but includes a flat internal ... the shell. The baffle slopes ... air flow to sweep the ...
Medicine Products: